Trial NCT04178460

View at ClinicalTrials.gov 
Org. Study IDs: ZL-2306-006

Last trial update was posted on 2022-06-01

MeSH Interventions

Niraparib

MeSH Conditions

Carcinoma Endometrial Neoplasms Triple Negative Breast Neoplasms

Other Conditions

Biliary Tract Carcinoma Endometrial Carcinoma Gastric Cancer Triple Negative Breast Cancer

Stopping Reasons

This termination decision is a business decision and is not due to any safety concerns.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID